BRITTANY MORGAN: Open Payments
NPI 1366076150 · HAZARD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 45 payments from 10 companies in 2025. Trend: 2023 $95 · 2024 $219 · 2025 $758
Food & beverage: $758
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $281 |
| ABBVIE INC. | 7 | $153 |
| Vanda Pharmaceuticals Inc. | 4 | $121 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| KYOWA KIRIN, INC. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Alkermes, Inc. | 2 | $30 |
| Verona Pharma, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, HETLIOZ, FANAPT, REXULTI, CRYSVITA, ARISTADA, QULIPTA.
Industry payments across KY — which companies pay providers there.
